See more : Nippon Sheet Glass Company, Limited (NPSGY) Income Statement Analysis – Financial Results
Complete financial analysis of Humana Inc. (HUM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Humana Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
You may be interested
- BLOK Technologies Inc. (BLPFF) Income Statement Analysis – Financial Results
- Specialty Liquid Transportation Corp. (SPQDF) Income Statement Analysis – Financial Results
- China-Hongkong Photo Products Holdings Limited (1123.HK) Income Statement Analysis – Financial Results
- RattanIndia Enterprises Limited (RTNINDIA.NS) Income Statement Analysis – Financial Results
- Qualis Innovations, Inc. (QLIS) Income Statement Analysis – Financial Results
Humana Inc. (HUM)
About Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 106.37B | 92.87B | 83.06B | 77.16B | 64.89B | 56.91B | 53.77B | 54.38B | 54.29B | 48.50B | 41.31B | 39.13B | 36.83B | 33.87B | 30.96B | 28.95B | 25.29B | 21.42B | 14.42B | 13.10B | 12.23B | 11.26B | 10.19B | 10.51B | 10.11B | 9.78B | 8.04B | 6.79B | 4.70B | 3.65B | 3.14B | 4.04B | 5.87B | 4.85B |
| Cost of Revenue | 13.19B | 12.67B | 10.12B | 10.05B | 7.38B | 7.53B | 6.57B | 7.28B | 7.32B | 7.64B | 6.36B | 5.83B | 5.40B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 93.19B | 80.20B | 72.94B | 67.10B | 57.51B | 49.39B | 47.20B | 47.10B | 46.97B | 40.86B | 34.96B | 33.30B | 31.44B | 33.87B | 30.96B | 28.95B | 25.29B | 21.42B | 14.42B | 13.10B | 12.23B | 11.26B | 10.19B | 10.51B | 10.11B | 9.78B | 8.04B | 6.79B | 4.70B | 3.65B | 3.14B | 4.04B | 5.87B | 4.85B |
| Gross Profit Ratio | 87.60% | 86.36% | 87.82% | 86.97% | 88.63% | 86.78% | 87.79% | 86.62% | 86.52% | 84.25% | 84.62% | 85.10% | 85.35% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.40B | 4.66B | 4.23B | 3.94B | 3.48B | 3.02B | 2.18B | 1.88B | 1.86B | 1.74B | 1.55B | 1.44B | 1.37B | 1.33B | 1.12B | 940.00M | 571.00M | 436.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 12.20B | 10.12B | 10.05B | 7.38B | 7.53B | 6.42B | 7.17B | 7.30B | 7.64B | 6.36B | 5.83B | 5.40B | 4.66B | 4.23B | 3.94B | 3.48B | 3.02B | 2.18B | 1.88B | 1.86B | 1.74B | 1.55B | 1.44B | 1.37B | 1.33B | 1.12B | 940.00M | 571.00M | 436.00M | 368.00M | 371.00M | 226.00M | 226.40M |
| Other Expenses | 102.36B | 76.87B | 69.20B | 62.15B | 53.80B | 47.10B | 43.09B | 45.47B | 44.38B | 38.50B | 32.90B | 31.28B | 29.09B | 27.08B | 24.81B | 23.93B | 20.46B | 17.57B | 11.80B | 10.79B | 10.01B | -12.77B | 8.44B | 8.93B | -11.85B | -10.86B | -8.86B | -7.70B | -4.97B | -3.81B | -3.36B | -4.11B | -5.44B | -4.48B |
| Operating Expenses | 102.36B | 89.07B | 79.32B | 72.20B | 61.18B | 54.62B | 49.51B | 52.64B | 51.67B | 46.14B | 39.25B | 37.11B | 34.49B | 31.74B | 29.04B | 27.87B | 23.93B | 20.59B | 13.98B | 12.67B | 11.86B | -11.03B | 9.99B | 10.37B | -10.48B | -9.53B | -7.75B | -6.76B | -4.40B | -3.37B | -2.99B | -3.74B | -5.21B | -4.25B |
| Cost & Expenses | 102.36B | 89.07B | 79.32B | 72.20B | 61.18B | 54.62B | 49.51B | 52.64B | 51.67B | 46.14B | 39.25B | 37.11B | 34.60B | 32.12B | 29.36B | 27.95B | 24.00B | 20.65B | 14.00B | 12.69B | 11.88B | 11.05B | 10.01B | 10.40B | 10.52B | 9.58B | 7.77B | 6.77B | 4.41B | 3.40B | 422.00M | 680.00M | 579.00M | 568.60M |
| Interest Income | 0.00 | 401.00M | 326.00M | 283.00M | 242.00M | 218.00M | 242.00M | 189.00M | 186.00M | 192.00M | 140.00M | 105.00M | 0.00 | 60.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 493.00M | 401.00M | 326.00M | 283.00M | 242.00M | 218.00M | 242.00M | 189.00M | 186.00M | 192.00M | 140.00M | 105.00M | 109.00M | 105.06M | 105.84M | 80.29M | 68.88M | 63.14M | 39.32M | 23.17M | 17.37M | 17.25M | 25.30M | 29.00M | 33.00M | 47.00M | 20.00M | 11.00M | 11.00M | 25.00M | 7.00M | 71.00M | 97.00M | 111.30M |
| Depreciation & Amortization | 917.00M | 845.00M | 713.00M | 616.00M | 575.00M | 534.00M | 485.00M | 465.00M | 447.00M | 449.00M | 426.00M | 338.00M | 303.00M | 262.91M | 250.27M | 220.35M | 184.81M | 148.60M | 128.86M | 117.79M | 126.78M | 120.73M | 171.02M | 147.00M | 124.00M | 128.00M | 108.00M | 98.00M | 70.00M | 50.00M | 47.00M | 238.00M | 256.00M | 230.90M |
| EBITDA | 4.93B | 4.68B | 4.34B | 5.45B | 4.17B | 2.85B | 4.75B | 2.21B | 3.06B | 2.81B | 2.49B | 2.35B | 2.54B | 2.12B | 1.85B | 1.29B | 1.47B | 910.68M | 550.57M | 533.64M | 488.86M | 347.92M | 369.91M | 290.00M | -247.45M | 331.00M | 128.00M | 116.00M | 81.00M | 307.00M | 54.00M | 309.00M | 353.00M | 342.20M |
| EBITDA Ratio | 4.63% | 5.00% | 5.37% | 7.22% | 6.61% | 4.97% | 8.83% | 4.06% | 5.64% | 5.80% | 6.02% | 6.02% | 6.89% | 5.94% | 5.98% | 4.19% | 5.83% | 4.25% | 3.82% | 4.07% | 3.86% | 2.94% | 3.47% | 2.48% | -2.77% | 3.38% | 4.70% | 1.71% | 7.61% | 8.40% | 88.05% | 89.07% | 94.49% | 93.04% |
| Operating Income | 4.01B | 3.80B | 3.75B | 4.96B | 3.71B | 2.29B | 4.26B | 1.74B | 2.62B | 2.36B | 2.06B | 2.02B | 2.24B | 1.75B | 1.60B | 992.85M | 1.29B | 762.09M | 421.71M | 415.85M | 344.72M | 209.93M | 183.08M | 114.00M | -404.00M | 203.00M | 270.00M | 18.00M | 288.00M | 257.00M | 2.72B | 3.36B | 5.29B | 4.28B |
| Operating Income Ratio | 3.77% | 4.09% | 4.51% | 6.42% | 5.72% | 4.03% | 7.93% | 3.20% | 4.82% | 4.87% | 4.99% | 5.15% | 6.07% | 5.17% | 5.17% | 3.43% | 5.10% | 3.56% | 2.92% | 3.17% | 2.82% | 1.86% | 1.80% | 1.08% | -3.99% | 2.08% | 3.36% | 0.27% | 6.13% | 7.03% | 86.55% | 83.18% | 90.13% | 88.28% |
| Total Other Income/Expenses | -630.00M | -232.00M | -391.00M | -386.00M | 264.00M | -1.04B | -242.00M | -189.00M | 84.00M | -192.00M | -140.00M | -105.00M | 5.29B | -105.06M | -105.84M | -80.29M | -68.69M | -63.45M | -20.41M | -23.17M | 0.00 | 0.00 | 0.00 | 0.00 | -404.84M | 203.08M | 0.00 | 0.00 | 0.00 | 257.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 3.38B | 3.57B | 3.35B | 4.60B | 3.46B | 2.06B | 4.02B | 1.55B | 2.43B | 2.17B | 1.92B | 1.91B | 2.24B | 1.75B | 1.60B | 992.85M | 1.29B | 762.09M | 421.71M | 415.85M | 344.72M | 209.93M | 183.08M | 114.00M | -404.00M | 203.00M | 270.00M | 18.00M | 288.00M | 257.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 3.18% | 3.84% | 4.04% | 5.96% | 5.33% | 3.62% | 7.48% | 2.85% | 4.48% | 4.47% | 4.65% | 4.88% | 6.07% | 5.17% | 5.17% | 3.43% | 5.10% | 3.56% | 2.92% | 3.17% | 2.82% | 1.86% | 1.80% | 1.08% | -3.99% | 2.08% | 3.36% | 0.27% | 6.13% | 7.03% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 836.00M | 762.00M | 485.00M | 1.31B | 763.00M | 391.00M | 1.57B | 938.00M | 1.16B | 1.02B | 690.00M | 689.00M | 816.00M | 650.17M | 562.09M | 345.69M | 455.62M | 274.66M | 113.23M | 135.84M | 115.78M | 67.18M | 65.91M | 24.00M | -22.00M | 74.00M | 97.00M | 6.00M | 98.00M | 81.00M | 54.00M | 109.00M | 200.00M | 180.50M |
| Net Income | 2.49B | 2.81B | 2.93B | 3.37B | 2.71B | 1.68B | 2.45B | 614.00M | 1.28B | 1.15B | 1.23B | 1.22B | 1.42B | 1.10B | 1.04B | 647.15M | 833.68M | 487.42M | 308.48M | 280.01M | 228.93M | 142.76M | 117.17M | 90.00M | -382.00M | 129.00M | 173.00M | 12.00M | 190.00M | 176.00M | 89.00M | 122.70M | 355.00M | 309.60M |
| Net Income Ratio | 2.34% | 3.02% | 3.53% | 4.36% | 4.17% | 2.96% | 4.55% | 1.13% | 2.35% | 2.36% | 2.98% | 3.12% | 3.85% | 3.25% | 3.36% | 2.24% | 3.30% | 2.28% | 2.14% | 2.14% | 1.87% | 1.27% | 1.15% | 0.86% | -3.78% | 1.32% | 2.15% | 0.18% | 4.04% | 4.82% | 2.84% | 3.03% | 6.05% | 6.38% |
| EPS | 20.09 | 22.20 | 22.79 | 25.47 | 20.20 | 12.24 | 16.94 | 4.11 | 8.54 | 7.44 | 7.81 | 7.56 | 8.58 | 6.55 | 6.21 | 3.87 | 5.00 | 2.97 | 1.91 | 1.75 | 1.41 | 0.85 | 0.71 | 0.54 | -2.28 | 0.77 | 1.06 | 0.07 | 1.17 | 1.10 | 0.56 | 0.77 | 2.26 | 3.00 |
| EPS Diluted | 20.00 | 22.08 | 22.67 | 25.31 | 20.10 | 12.16 | 16.81 | 4.07 | 8.44 | 7.36 | 7.73 | 7.47 | 8.46 | 6.47 | 6.15 | 3.83 | 4.91 | 2.90 | 1.87 | 1.72 | 1.38 | 0.83 | 0.70 | 0.54 | -2.28 | 0.77 | 1.05 | 0.07 | 1.16 | 1.10 | 0.55 | 0.77 | 2.26 | 3.00 |
| Weighted Avg Shares Out | 123.87M | 126.42M | 128.69M | 132.20M | 134.05M | 137.49M | 144.49M | 149.37M | 149.45M | 154.19M | 157.50M | 161.48M | 165.41M | 167.78M | 167.36M | 167.17M | 166.87M | 164.12M | 161.51M | 160.01M | 158.68M | 167.95M | 165.03M | 166.76M | 167.73M | 167.48M | 163.41M | 162.53M | 162.27M | 160.00M | 158.93M | 159.35M | 157.08M | 101.13M |
| Weighted Avg Shares Out (Dil) | 124.44M | 127.09M | 129.40M | 133.01M | 134.73M | 138.40M | 145.58M | 150.92M | 151.14M | 155.87M | 159.15M | 163.46M | 167.83M | 169.80M | 169.07M | 168.97M | 169.82M | 168.08M | 164.96M | 162.80M | 162.13M | 171.99M | 167.39M | 166.76M | 167.73M | 167.48M | 165.84M | 165.28M | 164.59M | 160.79M | 161.82M | 159.35M | 157.08M | 101.13M |
Cigna Restarts Talks To Buy Fallen Star Humana; 2024 Election Is Key
Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled.
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
In a significant development in the health insurance industry, Cigna Group CI has reinitiated discussions to merge with Humana Inc. HUM, potentially creating a giant in the sector.
2 Health Insurance Stocks Moving Amid Merger Talks
Shares of Humana Inc (NYSE:HUM) and Cigna Group (NYSE:CI) are making opposite moves today, as merger talks between the health insurance companies ramp up.
Watch These Humana Price Levels as Stock Jumps on Report of Merger Talks
Humana (HUM) shares surged in premarket trading Monday after Bloomberg reported late Friday that Cigna (CI) has resumed its efforts to merge with the struggling health insurer.
Cigna, Humana Resume Merger Talks, Report Says. Why It's Different This Time.
Key developments since the talks between the healthcare insurers broke down last year mean a deal now looks more likely.
Potential Cigna buyout of Humana is a ‘when,' not an ‘if,' analyst says
Humana's stock looked to rally Monday. And Mizuho analyst Ann Hynes said she believes a buyout by Cigna Group is likely — it's just a matter of timing.
Humana Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Humana Inc. (HUM)
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. Humana is the subject of a...
Humana Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / October 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Humana Inc. ("Humana" or "the Company") (NYSE:HUM) for violations...
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Humana Inc. (HUM) And Encourages Investors to Reach Out
NEW YORK CITY, NY / ACCESSWIRE / October 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). Investors who purchased Humana securities are encouraged to...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK, NY / ACCESSWIRE / October 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Source: https://incomestatements.info
Category: Stock Reports